Table 5.
Characteristics of non-citizens by ART status with detectable viremia.
| Overall N = 60 | TE N = 36 | TN N = 23 | p value | |
|---|---|---|---|---|
| Age, Median (Q1, Q3) | 43 (37, 47) | 43 (39, 47) | 39 (30, 45) | 0.02 |
| Gender | ||||
| Male, N (%) | 24 (40) | 16 (67) | 8(33) | 0.96 |
| Female, N (%) Unknown | 35 (58) 1 (2) | 20(57) | 15 (43) | |
| Geographical Origin | ||||
| Mozambique, N (%) | 1 (0.7) | 0 | 1 | |
| Tanzania, N (%) | 2 (1.3) | 2 | 0 | |
| Zimbabwe, N (%) | 57(95) | 34(60) | 22(40) | |
| HIV-1 RNA (Log10 Copies/mL), Median (Q1, Q3) | 3.7 (1.7, 5.9) | 4.0(2.6, 4.7) | 3.9(2.8, 4.8) | 0.66 |
Demographical, clinical, and virological characteristics of the study group with detectable viremia, stratified by ART status. Continuous variables values are expressed as median and first and third quartiles (Q1, Q3) (25–75 percentiles) and categorical variables are displayed as the number of cases (percentage and confidence interval-95% in parentheses). VL (viral load in Log10), TE (Treatment experienced), TN (Treatment Naive), N. Detectable viremia was defined as an HIV RNA level ≥ 40 copies/mL.